Topic: Biology

Researchers at the University of Geneva developed a new system using synthetic DNA strands that can identify cancer cells with high accuracy and release powerful drugs only where needed.

Cancer treatment is a major challenge. Doctors want to destroy cancer cells without harming healthy tissue. Scientists have now created a 'smart' system that uses synthetic DNA strands to target cancer cells. This approach could lead to programmable, responsive medicines in the future.

The new method relies on several separate DNA strands, each carrying a specific function. Some strands recognize cancer markers, while another carries a toxic drug. When two distinct cancer markers are present on a cell, the DNA components attach and assemble at that exact location, triggering a chain reaction that builds up more DNA structures and delivers the drug.

In laboratory experiments, the system successfully identified cancer cells with specific combinations of surface proteins and delivered potent drugs directly to them. Nearby healthy cells were not affected. The researchers also showed that multiple drugs can be delivered together using this approach, which could help prevent or overcome resistance in cancer treatment.

Why It Matters

This breakthrough has the potential to revolutionize cancer treatment by making it more precise and effective. It's an important step forward in medicine, especially for Indian students who may have family members or friends affected by cancer.

Key Facts

• Researchers at the University of Geneva developed a new system using synthetic DNA strands that can identify cancer cells with high accuracy and release powerful drugs only where needed.
• The system relies on several separate DNA strands, each carrying a specific function, to target cancer cells.
• In laboratory experiments, the system successfully identified cancer cells with specific combinations of surface proteins and delivered potent drugs directly to them.
• Multiple drugs can be delivered together using this approach, which could help prevent or overcome resistance in cancer treatment.
• The study was published in Nature Biotechnology on March 27, 2026.

Key Terms

Antibody-drug conjugates (ADCs)

A type of targeted therapy that uses monoclonal antibodies to carry treatments directly to cancer cells.

Implications

This breakthrough has the potential to revolutionize cancer treatment by making it more precise and effective. It's an important step forward in medicine, especially for Indian students who may have family members or friends affected by cancer.